Literature DB >> 31563860

Expression of several long noncoding RNAs in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Jie-Bing Wang1, Jun Li2, Tian-Ping Zhang3, Tian-Tian Lv3, Lian-Ju Li3, Jun Wu3, Rui-Xue Leng3, Yin-Guang Fan3, Hai-Feng Pan4, Dong-Qing Ye5.   

Abstract

PURPOSE: Accumulating evidence has linked long noncoding RNAs (lncRNAs) to autoimmune and inflammatory disorders. This study aimed to detect the expression levels of five lncRNAs (lnc0640, lnc3643, lnc5150, lnc7514 and lncagf) in peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE), as well as their correlation with clinical and laboratory features. MATERIALS/
METHODS: We recruited 76 patients with SLE and 71 normal controls into the present study, and obtained PBMCs from the blood samples of all study subjects. Expression levels of lncRNAs were determined by quantitative real-time reverse transcription polymerase chain reaction and their associations with clinical and laboratory characteristics were analyzed.
RESULTS: Lnc5150 expression levels were statistically significantly decreased (Z=-6.016, P < 0.001) compared with normal controls. Lnc3643 levels were also statistically significantly decreased in SLE patients with proteinuria compared with those without (Z=-2.934, P = 0.003), and the lnc7514 levels were statistically significantly lower in anti-dsDNA(+) patients compared with anti-dsDNA(-) patients. The expression levels of lnc3643 were correlated with C-reactive protein and erythrocyte sedimentation rate (ESR), lnc7514 was correlated with disease activity and ESR (all P < 0.01).
CONCLUSIONS: The aberrant lncRNA expression levels and their associations with laboratory features in SLE suggest their important role in SLE pathogenesis.
Copyright © 2019 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Long noncoding RNA; Lupus nephritis; Peripheral blood mononuclear cells; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 31563860     DOI: 10.1016/j.advms.2019.08.002

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  8 in total

Review 1.  Emerging Role of LncRNAs in Autoimmune Lupus.

Authors:  Wangdong Xu; Qian Wu; Anfang Huang
Journal:  Inflammation       Date:  2022-01-22       Impact factor: 4.092

2.  lncRNA expression profiles related to apoptosis and autophagy in peripheral blood mononuclear cells of patients with rheumatoid arthritis.

Authors:  Jianting Wen; Jian Liu; Hui Jiang; Lei Wan; Ling Xin; Yue Sun; Pingheng Zhang; Yanqiu Sun; Ying Zhang; Xinlei Du; Xin Wang; Jie Wang
Journal:  FEBS Open Bio       Date:  2020-07-22       Impact factor: 2.693

Review 3.  Exploring the Role of Non-Coding RNAs in the Pathophysiology of Systemic Lupus Erythematosus.

Authors:  Mohammad Taheri; Reyhane Eghtedarian; Marcel E Dinger; Soudeh Ghafouri-Fard
Journal:  Biomolecules       Date:  2020-06-22

Review 4.  Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.

Authors:  Gongjun Tan; Binila Baby; Yuqiu Zhou; Tianfu Wu
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

Review 5.  LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets.

Authors:  Han Wu; Shuxian Chen; Aifen Li; Kangyuan Shen; Shuting Wang; Sijie Wang; Ping Wu; Wenying Luo; Qingjun Pan
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

6.  IncRNAs and circRNAs provide insight into discoid lupus pathogenesis and progression.

Authors:  Michelle Le; Anastasiya Muntyanu; Elena Netchiporouk
Journal:  Ann Transl Med       Date:  2020-03

Review 7.  Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.

Authors:  Valeria Lodde; Giampaolo Murgia; Elena Rita Simula; Maristella Steri; Matteo Floris; Maria Laura Idda
Journal:  Biomolecules       Date:  2020-07-14

8.  Long non‑coding RNA expression profiles identify lncRNA‑XLOC_I2_006631 as a potential novel blood biomarker for Hashimoto's thyroiditis.

Authors:  Huiyong Peng; Si Xiong; Xiangmei Ding; Xinyi Tang; Xuehua Wang; Li Wang; Yingzhao Liu
Journal:  Int J Mol Med       Date:  2020-10-13       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.